Children included in randomised controlled trials of biologics in inflammatory bowel diseases do not represent the real‐world patient mix-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Children included in randomised controlled trials of biologics in inflammatory bowel diseases do not represent the real‐world patient mix

Published:2022-06-23 Issue:5 Volume:56 Page:794-801
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Atia Ohad¹²^ORCID,Pujol‐Muncunill Gemma³,Navas‐López Víctor Manuel⁴,Orlanski‐Meyer Esther¹²,Ledder Oren¹²,Lev‐Tzion Raffi¹,Focht Gili¹²,Shteyer Eyal¹²,Stein Ronen⁵,Aloi Marina⁶,Russell Richard K.⁷,Martin‐de‐Carpi Javier³,Turner Dan¹²

Affiliation:

1. Juliet Keidan Institute of Pediatric Gastroenterology Hepatology and Nutrition Shaare Zedek Medical Center Jerusalem Israel

2. The Faculty of Medicine The Hebrew University of Jerusalem Jerusalem Israel

3. Hospital Sant Joan de Déu Barcelona Spain

4. Hospital Regional Universitario de Málaga Málaga Spain

5. Children's Hospital of Philadelphia Philadelphia Pennsylvania USA

6. Sapienza University of Rome – Umberto I Hospital Rome Italy

7. The Royal Hospital for Children & Young People Edinburgh UK

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/apt.17092

Reference18 articles.

1. Systematic review with meta-analysis: comparative efficacy of immunosuppressants and biologics for reducing hospitalisation and surgery in Crohn's disease and ulcerative colitis

2. Emergent colectomy rates decreased while elective ileal pouch rates were stable over time: a nationwide inpatient sample study

3. Real-world Pattern of Biologic Use in Patients With Inflammatory Bowel Disease: Treatment Persistence, Switching, and Importance of Concurrent Immunosuppressive Therapy

4. Improved Outcomes of Paediatric and Adult Crohn’s Disease and Association With Emerging Use of Biologics–A Nationwide Study From the Epi-IIRN

5. Colectomy Rates did not Decrease in Paediatric- and Adult-Onset Ulcerative Colitis During the Biologics Era: A Nationwide Study From the epi-IIRN

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Durability of Adalimumab and Infliximab in Children With Crohn’s Disease: A Nationwide Comparison From the epi-IIRN Cohort;Inflammatory Bowel Diseases;2024-01-08

2. Effectiveness of strategies to suppress antibodies to infliximab in pediatric inflammatory bowel disease;Journal of Pediatric Gastroenterology and Nutrition;2023-12-05

3. Representation and reporting of diverse groups in randomised controlled trials of pharmacological agents in inflammatory bowel disease: a systematic review;The Lancet Gastroenterology & Hepatology;2023-12

4. Improved Clinical Outcomes With Early Anti-Tumour Necrosis Factor Alpha Therapy in Children With Newly Diagnosed Crohn’s Disease: Real-world Data from the International Prospective PIBD-SETQuality Inception Cohort Study;Journal of Crohn's and Colitis;2023-11-27

5. A Real-World Prospective Cohort Study of Patients With Newly Diagnosed Crohn’s Disease Treated by a Multidisciplinary Team: 1-Year Outcomes;Crohn's & Colitis 360;2023-10-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3